[Rethinking staging uncertainty and individualized decision-making in the management of clinical T2N0 esophageal squamous cell carcinoma]
{{output}}
Clinical T2N0 (cT2N0) esophageal squamous cell carcinoma (ESCC) represents a clinical grey zone between early-stage and locally advanced disease, and remains one of the most controversial scenarios in esophageal cancer management. The choice between upfront su... ...
